These products are sold exclusively for laboratory research use only. They are not intended for human or animal consumption, clinical use, or veterinary applications, and are not intended to diagnose, treat, cure, or prevent any disease.
For research use only. Not for human or veterinary use.






CAS: 62568-57-4
A nonapeptide neuromodulator that crosses the blood-brain barrier and has been studied for its ability to induce and prolong delta-wave sleep patterns, normalize disrupted circadian rhythms, and modulate HPA axis activity.
Research explores its role in sleep architecture optimization, cortisol regulation, stress resilience, and neurological homeostasis ? with potential relevance to models of chronic stress and circadian dysregulation.
For research use only. Not for human or veterinary use. Not for injection.
SALE
SALE
SALE
SALE
SALE
SALE
SALE
SALE
SALE
SALE
SALE
SALE
SALE
SALE
SALE
SALE
SALE
SALE
SALEAll products available on this website are strictly intended for laboratory research and scientific identification purposes. These compounds are not designed, labeled, or intended for human use, injection, dosing, or ingestion.
No statements on this website have been reviewed or approved by the U.S. Food and Drug Administration. The products and information provided by Bermuda Peptides are not intended to diagnose, treat, cure, or prevent any disease or medical condition. All compounds are exclusively for in-vitro and pre-clinical laboratory research use.
Bermuda Peptides operates as a raw material supplier of research-grade compounds. We are not a compounding pharmacy, clinical laboratory, or compounding facility as defined under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
THE COMPOUNDS OFFERED ON THIS SITE ARE INTENDED SOLELY FOR IN-VITRO AND PRE-CLINICAL RESEARCH. BY PURCHASING FROM BERMUDA PEPTIDES, THE CUSTOMER ACKNOWLEDGES THE INHERENT RISKS ASSOCIATED WITH HANDLING THESE MATERIALS AND CONFIRMS THAT THEY POSSESS THE APPROPRIATE KNOWLEDGE, EQUIPMENT, AND FACILITIES TO DO SO RESPONSIBLY.
